Glenview Trust CO Abb Vie Inc. Transaction History

Glenview Trust CO

  • $5.13 Billion
  • Q3 2024

A detailed history of Glenview Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Glenview Trust CO holds 409,821 shares of ABBV stock, worth $73.8 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
409,821
Previous 407,143 0.66%
Holding current value
$73.8 Million
Previous $69.8 Million 15.89%
% of portfolio
1.58%
Previous 1.44%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$163.84 - $199.33 $438,763 - $533,805
2,678 Added 0.66%
409,821 $80.9 Million
Q2 2024

Aug 14, 2024
BUY
$154.79 - $180.76 $395,798 - $462,203
2,557 Added 0.63%
407,143 $69.8 Million
Q1 2024

May 14, 2024
BUY
$159.82 - $182.1 $2.04 Million - $2.33 Million
12,772 Added 3.26%
404,586 $73.7 Million
Q4 2023

Feb 12, 2024
BUY
$137.6 - $154.97 $2.04 Million - $2.3 Million
14,860 Added 3.94%
391,814 $60.7 Million
Q3 2023

Nov 13, 2023
BUY
$133.59 - $154.65 $2.02 Million - $2.34 Million
15,157 Added 4.19%
376,954 $56.2 Million
Q2 2023

Aug 14, 2023
BUY
$132.51 - $164.9 $630,615 - $784,759
4,759 Added 1.33%
361,797 $48.7 Million
Q1 2023

May 09, 2023
BUY
$144.61 - $166.54 $482,418 - $555,577
3,336 Added 0.94%
357,038 $56.9 Million
Q4 2022

Feb 08, 2023
BUY
$138.31 - $165.87 $1.01 Million - $1.21 Million
7,279 Added 2.1%
353,702 $57.2 Million
Q3 2022

Nov 04, 2022
BUY
$134.21 - $153.93 $766,607 - $879,248
5,712 Added 1.68%
346,423 $46.5 Million
Q2 2022

Aug 10, 2022
BUY
$137.62 - $174.96 $693,880 - $882,148
5,042 Added 1.5%
340,711 $52.2 Million
Q1 2022

May 11, 2022
BUY
$131.98 - $163.75 $3.14 Million - $3.9 Million
23,802 Added 7.63%
335,669 $54.4 Million
Q4 2021

Feb 10, 2022
SELL
$107.43 - $135.93 $700,765 - $886,671
-6,523 Reduced 2.05%
311,867 $42.2 Million
Q3 2021

Nov 12, 2021
BUY
$106.4 - $120.78 $1.42 Million - $1.61 Million
13,350 Added 4.38%
318,390 $34.3 Million
Q2 2021

Aug 11, 2021
BUY
$105.21 - $117.21 $12.2 Million - $13.6 Million
116,370 Added 61.68%
305,040 $34.4 Million
Q1 2021

May 12, 2021
BUY
$102.3 - $112.62 $268,128 - $295,177
2,621 Added 1.41%
188,670 $20.4 Million
Q4 2020

Feb 02, 2021
BUY
$80.49 - $108.67 $13,039 - $17,604
162 Added 0.09%
186,049 $19.9 Million
Q3 2020

Nov 12, 2020
SELL
$85.91 - $100.83 $137,799 - $161,731
-1,604 Reduced 0.86%
185,887 $16.3 Million
Q2 2020

Aug 12, 2020
BUY
$73.37 - $98.18 $41,307 - $55,275
563 Added 0.3%
187,491 $18.4 Million
Q1 2020

Apr 28, 2020
SELL
$64.5 - $97.79 $286,767 - $434,774
-4,446 Reduced 2.32%
186,928 $14.2 Million
Q4 2019

Feb 06, 2020
BUY
$72.13 - $90.25 $368,656 - $461,267
5,111 Added 2.74%
191,374 $16.9 Million
Q3 2019

Nov 14, 2019
SELL
$62.98 - $75.72 $102,972 - $123,802
-1,635 Reduced 0.87%
186,263 $14.1 Million
Q2 2019

Aug 08, 2019
SELL
$65.7 - $83.98 $483,946 - $618,596
-7,366 Reduced 3.77%
187,898 $0
Q1 2019

May 14, 2019
SELL
$77.14 - $90.79 $775,951 - $913,256
-10,059 Reduced 4.9%
195,264 $15.7 Million
Q4 2018

Feb 14, 2019
BUY
$77.85 - $96.01 $31,996 - $39,460
411 Added 0.2%
205,323 $18.9 Million
Q3 2018

Nov 14, 2018
SELL
$88.91 - $98.84 $223,964 - $248,977
-2,519 Reduced 1.21%
204,912 $19.4 Million
Q2 2018

Aug 10, 2018
SELL
$89.78 - $106.23 $460,122 - $544,428
-5,125 Reduced 2.41%
207,431 $19.2 Million
Q1 2018

May 14, 2018
SELL
$92.01 - $123.21 $359,943 - $481,997
-3,912 Reduced 1.81%
212,556 $0
Q4 2017

Feb 06, 2018
SELL
$89.56 - $98.21 $254,887 - $279,505
-2,846 Reduced 1.3%
216,468 $20.9 Million
Q3 2017

Nov 07, 2017
BUY
$69.85 - $89.22 $15.3 Million - $19.6 Million
219,314
219,314 $19.5 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Glenview Trust CO Portfolio

Follow Glenview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email